Material Agreements

STURM RUGER & CO INC entered into Cooperation Agreement with Beretta Holding S.A. with Beretta Holding S.A. valued at Agreement regarding Beretta Holding's shareholding, board composition, ownership cap, and tender off (effective 2026-05-02).

“On May 2, 2026, Sturm Ruger & Company, Inc. (“ Ruger ” or the “ Company ”) entered into an agreement (the “ Agreement ”) with Beretta Holding S.A. (“ Beretta Holding ”), regarding Beretta Holding’s shareholding in the Company, matters related to the composition of the Company’s board of directors (the “ Board ”) and certain other matters.”

CHARLES & COLVARD LTD entered into Asset Purchase Agreement with Van Lang Jewelry LLC or its affiliate Jewelry Design Partners LLC valued at Asset Purchase Agreement (effective 2026-04-15).

“The information set forth under Item 1.01 of this Current Report on Form 8-K regarding the Asset Purchase Agreement (the “Purchase Agreement”) with Van Lang Jewelry LLC or its affiliate Jewelry Design Partners LLC (the “Buyer”), dated as of April 15, 2026, is incorporated herein by reference.”

CROWN CASTLE INC. terminated Existing Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent, and the lenders and issuing banks from time to time party thereto (effective 2026-05-01).

“On May 1, 2026, in connection with the effectiveness of the New Credit Facility, the Company terminated the commitments under the Credit Agreement dated as of January 21, 2016 (as amended, "Existing Credit Agreement"), among the Company, the lenders and issuing banks from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent.”

CROWN CASTLE INC. entered into New Credit Facility with JPMorgan Chase Bank N.A., as administrative agent, and the lenders and issuing banks from time to time party thereto valued at $4.5 billion (effective 2026-05-01).

“On May 1, 2026, Crown Castle Inc., a Delaware corporation ("Company"), entered into a credit agreement ("New Credit Facility") with the lenders and issuing banks from time to time party thereto and JPMorgan Chase Bank N.A., as administrative agent.”

BEASLEY BROADCAST GROUP INC entered into 2027 PIK Notes Indenture with Wilmington Trust, National Association valued at $98,475,254 (effective 2026-05-01).

“The 2027 PIK Notes were issued pursuant to an indenture, dated as of May 1, 2026 (the “2027 PIK Notes Indenture”), among the Issuer, the guarantors named therein and Wilmington Trust, National Association, as trustee and collateral agent.”

Cineverse Corp. entered into Exchange Agreement with OCI-Cinedigm, LLC (effective 2026-04-27).

“On April 27, 2026, Cineverse Corp. (the “Company”) entered into an exchange agreement (the “Exchange Agreement”) with OCI-Cinedigm, LLC, a holder of shares of the Company’s Series A Preferred (the “Preferred Stock”).”

HERBALIFE LTD. entered into Ninth Amendment to Credit Agreement (Term A Facility and Revolving Credit Facility) with Coöperatieve Rabobank U.A., New York Branch valued at Term A Facility of $225 million and Revolving Credit Facility of $425 million; interest at Term SOFR (effective 2026-04-29).

“On April 29, 2026, the Company, HLF Financing, HII, Herbalife International Luxembourg S.à R.L., HBL IHB Operations S.à r.l., certain subsidiaries of the Company party thereto as guarantors, the lenders party thereto, each issuing bank, Citizens Bank, N.A., as collateral agent and Coöperatieve Rabobank U.A., New York Branch (“Rabobank”), as administrative agent for the lenders under the term loan A facility (the “Term A Facility”) and as administrative agent for the revolving credit facility (the “Revolving Credit Facility”), entered into a ninth amendment (the “Amendment”) to the Credit Agreement dated as of August 16, 2018 (as so amended, the “Credit Agreement”).”

HERBALIFE LTD. entered into Indenture for 7.750% Senior Secured Notes due 2033 with Citibank, N.A. valued at $800 million aggregate principal amount; 7.750% interest payable semi-annually; maturity May 1, 2033 (effective 2026-04-29).

“On April 29, 2026, HLF Financing SaRL, LLC (“HLF Financing”) and Herbalife International, Inc. (“HII” and together with HLF Financing, the “Issuers”), each a wholly owned subsidiary of Herbalife Ltd., a Cayman Islands exempted company incorporated with limited liability (the “Company”), issued $800 million aggregate principal amount of 7.750% Senior Secured Notes due 2033 (the “Notes”) to certain initial purchasers (the “Offering”).”

Big Digital Energy, Inc. entered into Joint Mining Agreement with Big Digital Energy, LLC valued at Profit-sharing colocation agreement for 25,000 mining computers and 75MW capacity with 50/50 profit (effective 2026-04-27).

“On April 27, 2026, Big Digital Energy, Inc. (“Big Digital” or the “Company”), formerly known as Mawson Infrastructure Group Inc., entered into a Joint Mining Agreement with Big Digital Energy, LLC (“BDE”), (the “Colocation Agreement” or “Agreement”).”

MARCHEX INC entered into Sublease with RentSpree, Inc. valued at approximately $337,000 (effective 2026-04-29).

“On April 29, 2026, Marchex, Inc., a Delaware corporation (the “Company”) entered into a Sublease Agreement (the “Sublease”) with RentSpree, Inc., a Delaware corporation (“RentSpree”), with respect to the sublease of the Company’s office space located at 1200 5 th Avenue, Suite 1300, Seattle, Washington. The term of the Sublease is May 1, 2026 through September 28, 2027 (the “Term”) and is for all 12,300 square feet. Under the Sublease, RentSpree is obligated to pay to the Company fixed monthly rent over the Term totaling approximately $337,000, with an initial rate of $19.25 per square foot increasing after 12 months to $19.50 per square foot.”

Dror Ortho-Design, Inc. entered into Securities Purchase Agreement with each of the purchasers signatory thereto (effective 2026-04-28).

“On April 28, 2026, Dror Ortho-Design, Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with each of the purchasers signatory thereto (each, a “Purchaser” and, collectively the “Purchasers”).”

HNO International, Inc. entered into Registration Rights Agreement with Lambda Ventures LLC (effective 2026-04-27).

“In connection with the Purchase Agreement, on April 27, 2026, the Company also entered into a Registration Rights Agreement (the “Registration Rights Agreement”) with the Investor, pursuant to which the Company agreed to file a registration statement with the Securities and Exchange Commission within thirty (30) calendar days from the date of the Registration Rights Agreement, covering the resale of the shares of Common Stock issuable under the Purchase Agreement, including the Initial Commitment Shares and Fulfillment Commitment.”

HNO International, Inc. entered into Equity Purchase Agreement with Lambda Ventures LLC valued at up to Thirty Million Dollars ($30,000,000) (effective 2026-04-27).

“On April 27, 2026, HNO International Inc., a Nevada corporation (the “Company”), entered into an Equity Purchase Agreement (the “Purchase Agreement”) with Lambda Ventures LLC, a Nevada limited liability company (the “Investor”). Pursuant to the Purchase Agreement, the Company has the right, but not the obligation, to direct the Investor to purchase up to Thirty Million Dollars ($30,000,000) of the Company’s common stock, $0.001 par value per share (the “Common Stock”), over a period of up to twenty-four (24) months, subject to the terms and conditions set forth in the Purchase Agreement.”

22nd Century Group, Inc. entered into Sales Agreement with Needham & Company, LLC (effective 2026-05-01).

“On May 1, 2026, 22nd Century Group, Inc. (the “Company”) filed with the Securities and Exchange Commission a prospectus supplement to its Registration Statement on Form S-3 (Registration No. 333-294792) permitting the Company to sell $6,400,000 shares of the Company’s common stock pursuant to its sales agreement (as amended, the “Sales Agreement”) with Needham & Company, LLC.”

Beam Global terminated Lease for headquarters at 5660 Eastgate Drive, San Diego, California 92121 with PNN Holdings, LP valued at Lease terminated on July 26, 2026; no material early termination penalties (effective 2026-07-26).

“On April 27, 2026, Beam Global (the “Company”) received written notice from PNN Holdings, LP (the “Landlord”) that the Landlord had exercised its right to terminate the lease for the Company’s headquarters located at 5660 Eastgate Drive, San Diego, California 92121 (the “Lease”). The Lease, which was extended on January 26, 2026, and was scheduled to expire on September 30, 2026, will now terminate on July 26, 2026.”

Sterling Real Estate Trust amended Amended and Restated Redemption Plans valued at from $75.0 million to $100.0 million (effective 2026-03-19).

“On March 19, 2026, the Company amended its Redemption Plans to increase the aggregate maximum amount of shares and units that may be redeemed from $75.0 million to $100.0 million effective March 19, 2026.”

Netcapital Inc. entered into a credit facility with Netcapital Systems LLC valued at total principal amount of $300,000 (effective 2026-04-30).

“On April 30, 2026, the Company also issued one unsecured, non-convertible promissory note in the total principal amount of $300,000, for gross proceeds of $150,000, reflecting a 50% original issue discount.”

Netcapital Inc. entered into Securities Purchase Agreements with Vanquish Funding Group Inc. valued at aggregate principal amount of $144,550 (effective 2026-04-26).

“On April 26, 2026, Netcapital Inc. (the “Company”) entered into two Securities Purchase Agreements with Vanquish Funding Group Inc., a Virginia corporation, pursuant to which the Company issued two promissory notes in the aggregate principal amount of $144,550 for an aggregate purchase price of $125,000, reflecting an aggregate original issue discount of $19,550.”

Esperion Therapeutics, Inc. entered into Agreement and Plan of Merger with Essence Parent Inc. valued at Merger consideration of $3.16 per share plus contingent value rights (effective 2026-05-01).

“On May 1, 2026, Esperion Therapeutics, Inc. (the “ Company ”) entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Essence Parent Inc., a Delaware corporation (“ Parent ”), and Essence MergerCo Inc., a Delaware corporation and wholly owned subsidiary of Parent (“ MergerCo ”), pursuant to which, subject to the terms and conditions thereof, MergerCo will merge with and into the Company with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent (the “ Merger ”).”

PDS Biotechnology Corp entered into Securities Purchase Agreement with YA II PN, LTD. valued at $6,000,000 (effective 2026-04-30).

“On April 30, 2026 (the “ Effective Date ”), PDS Biotechnology Corporation, a Delaware corporation (the “ Company ”), entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with YA II PN, LTD.”

iQSTEL Inc entered into Registration Rights Agreement with M2B Funding Corp. (effective 2026-04-30).

“On April 30, 2026, IQSTEL, Inc. (the “Company”) entered into (i) an Equity Purchase Agreement (the “Purchase Agreement”) and (ii) a Registration Rights Agreement (the “Registration Rights Agreement”) with M2B Funding Corp. (the “Investor”).”

iQSTEL Inc entered into Equity Purchase Agreement with M2B Funding Corp. valued at up to $50,000,000 (effective 2026-04-30).

“On April 30, 2026, IQSTEL, Inc. (the “Company”) entered into (i) an Equity Purchase Agreement (the “Purchase Agreement”) and (ii) a Registration Rights Agreement (the “Registration Rights Agreement”) with M2B Funding Corp. (the “Investor”). Pursuant to the Purchase Agreement, the Company may, from time to time during the Commitment Period, require the Investor to purchase up to $50,000,000 of the Company’s common stock”

Lunai Bioworks Inc. entered into Merger Agreement (effective 2026-05-01).

“The foregoing description of the Merger Agreement is a summary only and is qualified in its entirety by reference to the full text of the Merger Agreement, a copy of which is filed as Exhibit 2.1 to this Current”

authID Inc. entered into Securities Purchase Agreement with Madison Global Partners, LLC and each purchaser identified on Annex A valued at aggregate original principal amount of up to $4,000,000 (effective 2026-04-27).

“This Securities Purchase Agreement (this “ Agreement ”) is dated as of April 27, 2026, and is by and between authID Inc., a Delaware corporation (the “ Company ”), and each purchaser identified on the Annex A hereto (each, including its successors and assigns, an “ Investor ” or “ Holder ”) and collectively, the “ Investors ”).”

National Healthcare Properties, Inc. amended Amended and Restated Agreement of Limited Partnership with National Healthcare Properties Operating Partnership, L.P. (effective 2026-04-30).

“the Company, as general partner of National Healthcare Properties Operating Partnership, L.P., a Delaware limited partnership (the “Operating Partnership”), entered into the Amended and Restated Agreement of Limited Partnership, dated April 30, 2026 (the “A&R OP Agreement”).”

Clearway Energy, Inc. entered into Voting Trust Agreement with Clearway Energy Group LLC (effective 2026-04-29).

“On April 29, 2026, Clearway Energy Group LLC ("CEG"), the owner of all of the Company’s outstanding shares of Class B common stock, par value $0.01 per share (the "Class B common stock"), and Class D common stock, par value $0.01 per share (the "Class D common stock"), entered into a Voting Trust Agreement (the "Voting Trust Agreement") with Wilmington Trust, National Association, as the voting trustee thereunder (the "Voting Trustee"),”

BIOTRICITY INC. entered into Exchange Agreement with Holders of Exchange Securities valued at Exchange of 14,144,325 common shares, options for 3,992,427 shares, and warrants for 1,436,216 share (effective 2026-05-01).

“On May 1, 2026, Biotricity Inc. (the “Company”) entered into exchange agreements with holders (the “Exchange Holders”) of an aggregate of 14,144,325 shares of the Company’s common stock (the “Exchange Shares”), options (the “Exchange Options”) to purchase 3,992,427 shares of common stock of the Company, and warrants (the “Exchange Warrants,” and together with the Exchange Shares and the Exchange Options, the “Exchange Securities”) to purchase 1,436,216 shares of common stock of the Company.”

Cue Biopharma, Inc. entered into License Agreement with Ascendant Health Sciences Ltd. valued at $15.0 million as the upfront payment, up to an aggregate of $676.5 million in additional potential m (effective 2026-04-30).

“On April 30, 2026, Cue Biopharma, Inc. (the “Company”) entered into a License Agreement (the “License Agreement”) with Ascendant Health Sciences Ltd., a Cayman Limited Company (the “Licensor”).”

Olema Pharmaceuticals, Inc. entered into Lease with KR Oyster Point II, LLC (effective 2026-04-27).

“On April 27, 2026, Olema Pharmaceuticals, Inc. (the “Company”) entered into a lease agreement (the “Lease”) with KR Oyster Point II, LLC, a Delaware limited liability company (the “Landlord”)”

Shuttle Pharmaceuticals Holdings, Inc. entered into Agreement and Plan of Merger with United Dogecoin Inc. valued at Merger consideration consisting of Series B-1 convertible preferred stock and up to 118,038,551 pre- (effective 2026-04-30).

“On April 30, 2026, Shuttle Pharmaceuticals Holdings, Inc., a Delaware corporation (“ Shuttle ” or “ Acquiror ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Shuttle Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Shuttle (“ Merger Sub ”) and United Dogecoin Inc., a Delaware corporation (the “ Company ”).”

Z Squared Inc. entered into Binding Letter of Intent with MN Data Centers JV LLC and Claw Holdings, LLC valued at $18,000,000 (effective 2026-04-28).

“On April 28, 2026, Z Squared Inc. (the “Company”) entered into a Binding Letter of Intent (the “LOI”) with MN Data Centers JV LLC, a Delaware limited liability company holding 80% of the membership interests of Skycore Digital LLC, a North Carolina limited liability company (“Skycore”), and Claw Holdings, LLC, a North Carolina limited liability company holding the remaining 20% of such membership interests (collectively, the “Sellers”), pursuant to which the Company has agreed to acquire 100% of the issued and outstanding membership interests of Skycore (the “Skycore Acquisition”).”

Third Coast Bancshares, Inc. amended Renewal, Extension and Modification of Loan with American National Bank & Trust valued at $70,000,000 (effective 2026-03-10).

“Third Coast Bancshares, Inc. (the “Company”) entered into a Renewal, Extension and Modification of Loan (the “Amendment”) of the Loan Agreement, dated March 10, 2021, by and between the Company and American National Bank & Trust (the “Loan Agreement”).”

DeFi Development Corp. entered into Sales Agreement with R.F. Lafferty & Co., Inc. valued at $200 million (effective 2026-05-01).

“On May 1, 2026, DeFi Development Corp. (the “Company”) entered into a sales agreement (the “Sales Agreement”) with R.F. Lafferty & Co., Inc., acting as sales agent or principal (the “Agent”), pursuant to which the Company may offer and sell from time to time, through or to the Agent, up to an aggregate of $200 million of the Company’s common stock”

Blue Owl Credit Income Corp. amended Amended and Restated Collateral Management Agreement with Blue Owl Credit Advisors LLC (effective 2026-04-27).

“BOCA will serve as collateral manager for the Issuer under an amended and restated collateral management agreement dated as of the First Refinancing Date (the “Amended and Restated Collateral Management Agreement”).”

Blue Owl Credit Income Corp. amended BOCIC Loan Sale Agreement with Owl Rock CLO XI, LLC (effective 2026-04-27).

“the Company entered into an amended and restated loan sale agreement dated as of the First Refinancing Date (the “BOCIC Loan Sale Agreement”)”

Blue Owl Credit Income Corp. entered into A-2-RL Loan Agreement with State Street Bank and Trust Company (effective 2026-04-27).

“The Class A-2-RL Loans were borrowed under a loan agreement (the “A-2-RL Loan Agreement”), dated as of the First Refinancing Date, by and among the Issuer, as borrower, the lenders party thereto, and State Street Bank and Trust Company, as collateral trustee and loan agent.”

Blue Owl Credit Income Corp. entered into A-1-RL Loan Agreement with State Street Bank and Trust Company (effective 2026-04-27).

“The CLO Refinancing was executed by (A) the issuance of the following classes of notes pursuant to an amended and restated indenture and security agreement dated as of the First Refinancing Date (the “Indenture”), by and between the Issuer and State Street Bank and Trust Company: (i) $82 million of AAA(sf) Class A-R Notes, which initially bear interest at Benchmark plus 1.45% and (ii) $40 million of AA(sf) Class B-R Notes, which initially bear interest at Benchmark plus 2.00% (together, the “Secured Notes”) and (B) the borrowing by the Issuer of (i) $50 million under floating rate Class A-1-RL loans (the “Class A-1-RL Loans”) and (ii) $100 million under floating rate Class A-2-RL loans (the “Class A-2-RL Loans”, and together with the Class A-1-RL Loans and Secured Notes, the “Debt”).”

Blue Owl Credit Income Corp. entered into Indenture with State Street Bank and Trust Company valued at $395,820,000 (effective 2026-04-27).

“On April 27, 2026 (the “First Refinancing Date”), Blue Owl Credit Income Corp. (the “Company”) completed a $395,820,000 term debt securitization refinancing (the “CLO Refinancing”)”

NEXTNRG, INC. entered into Business Loan and Security Agreement with Venture Debt, LLC valued at $1,000,000 (effective 2026-04-27).

“On April 27, 2026, NextNRG, Inc. (the “Company”) entered into a Business Loan and Security Agreement (the “Venture Debt Agreement”), dated as of April 27, 2026, with Venture Debt, LLC (“Venture Debt”), pursuant to which Venture Debt provided the Company a loan in the principal amount of $1,000,000”

Veradermics, Inc entered into Purchase Agreement with certain entities affiliated with Suvretta Capital valued at approximately $30.0 million (effective 2026-04-29).

“On May 1, 2026, the Company closed a private placement (“the Private Placement”) pursuant to a Securities Purchase Agreement (the “Purchase Agreement”), dated April 29, 2026, among the Company and certain entities affiliated with Suvretta Capital (each, an “Investor” and collectively, the “Investors”), in which the Company sold to the Investors pre-funded warrants (the “Pre-Funded Warrants”) to purchase an aggregate of 300,000 shares of Common Stock, at an offering price of $99.99999 per Pre-Funded Warrant. The gross proceeds of the Private Placement were approximately $30.0 million”

Borealis Foods Inc. entered into Conversion Agreement with Oxus Capital PTE Ltd., Reza Soltanzadeh, Barthelemy Helg valued at $29.1 million (effective 2026-04-27).

“on the Closing Date, the Company and certain of its subsidiaries entered into a Conversion Agreement (the "Conversion Agreement") with Oxus Capital PTE Ltd. (the Company's former SPAC sponsor and a significant shareholder), Reza Soltanzadeh (the Company's Chief Executive Officer and co-founder) and Barthelemy Helg (the Company's Chairman of the Board and co-founder) (collectively, the "Shareholders").”

Borealis Foods Inc. entered into Credit Agreement with Oxus Capital Pte Ltd. valued at $17.0 million (effective 2026-04-27).

“On April 27, 2026 (the "Closing Date"), Palmetto Gourmet Foods, Inc., PGF Real Estate I, Inc., and PGF Real Estate II, Inc. (collectively, the "Borrowers"), each a wholly owned subsidiary of Borealis Foods Inc. (the "Company"), entered into a Credit Agreement (the "Credit Agreement") with Oxus Capital PTE Ltd. ("Oxus"), as lender.”

Senti Biosciences, Inc. entered into Securities Purchase Agreement with an entity affiliated with Celadon Partners SPV 24 valued at $40.0 million (effective 2026-04-27).

“On April 27, 2026, Senti Biosciences Holdings, Inc. (the “Company”), Senti Holdings, Inc., a direct, wholly owned subsidiary of the Company (“Senti Holdings”), and Senti Biosciences, Inc., a direct wholly owned subsidiary of Senti Biosciences Holdings (“Senti Biosciences”), entered into a securities purchase agreement (the “Securities Purchase Agreement”) with one accredited investor (the “Investor”), pursuant to which Senti Holdings agreed to issue and sell in a private placement up to $40.0 million in aggregate principal amount of its Senior Secured Convertible Notes (the “Notes”) in up to two tranches, subject to the satisfaction of certain specified closing conditions.”

DevvStream Corp. entered into Securities Purchase Agreement with Helena Partners Inc. valued at aggregate gross proceeds to the Company of $250,000 (effective 2026-04-27).

“On April 27, 2026, DevvStream Corp. (the “Company”) entered into a Securities Purchase Agreement (the “SPA”) with Helena Partners Inc. (the “Investor”), pursuant to which the Company agreed to issue and sell to the Investor, in a private placement, pre-funded warrants (the “Pre-Funded Warrants”) to purchase an aggregate of 250,025 shares of the Company’s common shares (the “Warrant Shares”) at a purchase price of $0.9999 per Pre-Funded Warrant, for aggregate gross proceeds to the Company of $250,000 (the “Offering”).”

CERO THERAPEUTICS HOLDINGS, INC. entered into Note with Keystone Capital Partners, LLC valued at $400,000 (effective 2026-04-27).

“On April 27, 2026, CERo Therapeutics Holdings, Inc., a Delaware corporation (the “Company”) issued and sold a convertible promissory note for an purchase price of $400,000, having a principal face value of $500,000 (the “Note”) to Keystone Capital Partners, LLC (“Lender”).”

Eightco Holdings Inc. entered into Amended and Restated Consulting Agreement with Worldcoin Tower LLC valued at 1.00% per annum of assets under management (effective 2026-05-01).

“On May 1, 2026, Eightco Holdings Inc. (the “Company”) entered into an Amended and Restated Consulting Agreement (the “A&R DACA”) with Worldcoin Tower LLC (the “Consultant”), which amends and restates in its entirety the Consulting Agreement dated as of September 9, 2025, between the Company and the Consultant (the “Original DACA”)”

USCB FINANCIAL HOLDINGS, INC. terminated Side Letter Agreement with Patriot Financial Partners II, L.P. and Patriot Financial Partners Parallel II, L.P. (effective 2026-04-29).

“On April 29, 2026, USCB Financial Holdings, Inc. (the Company”) and its wholly owned subsidiary, U.S. Century Bank (the “Bank” and collectively with the Company, the “USCB Parties”)) entered into a Mutual Termination Agreement with Patriot Financial Partners II, L.P. (“Patriot Financial”) and Patriot Financial Partners Parallel II, L.P. ("Patriot Financial Parallel” and together with Patriot Financial, “Patriot”), to terminate the rights and obligations of the Patriot and the USCB parties set forth in the Side Letter Agreement dated December 30, 2021 (the “Side Letter Agreement”) entered into by and among the Company, the Bank, Patriot and Priam Capital Fund II, LP (“Priam”).”

Diameter Credit Co amended Amendment No. 5 to Credit and Security Agreement with DCC Holdings, Citibank, N.A., Siepe, LLC, and the lenders party thereto valued at $500,000,000 (effective 2026-04-24).

“On April 24, 2026, Diameter Credit Company Holdings LLC (“ DCC Holdings ”), a wholly owned subsidiary of Diameter Credit Company, a Delaware statutory trust (the “ Company ”), entered into Amendment No. 5 (“ Amendment No. 5 ”) to its Credit and Security Agreement (as amended, restated or otherwise modified from time to time, including pursuant to the Amendment No. 1 to Credit and Security Agreement, dated as of May 22, 2024, the Amendment No. 2 to Credit and Security Agreement, dated as of January 14, 2025, the Amendment No. 3 to Credit and Security Agreement, dated as of August 1, 2025, the Amendment No. 4 to Credit and Security Agreement, dated as of December 12, 2025 and as further amended by Amendment No. 5, the “ Secured Credit Facility ”), dated as of January 10, 2024, by and among DCC Holdings, as borrower, the Company, in its capacity as collateral manager and in its capacity as equity holder, the lenders from time to time parties thereto, Citibank, N.A., as administrative agen”

Helio Corp /FL/ entered into Wolf Settlement Agreement with Sean Wolf valued at $879,163 (effective 2026-04-27).

“On April 27, 2026, Helio Corporation (the “ Company ”) entered into a binding settlement agreement (the “ Wolf Settlement Agreement” ) with Sean Wolf (“ Wolf ”)”

FibroBiologics, Inc. entered into At The Market Offering Agreement with H.C. Wainwright & Co., LLC valued at up to $6,150,000 (effective 2026-05-01).

“On May 1, 2026, FibroBiologics, Inc. (the “Company”) entered into an At The Market Offering Agreement (the “Sales Agreement”) with H.C. Wainwright & Co., LLC (the “Sales Agent”) under which the Company may issue and sell in a registered offering shares of its common stock, par value $0.00001 per share (the “Common Stock”), having an aggregate offering price of up to $6,150,000”